| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 22, 2025 5:30 P.M. |
| Form: | F-3 | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo, President and CEO: Kouji Eguchi, NASDAQ:NASDAQ, hereinafter "MEDIROM"), a company engaged in diversified healthcare businesses, has entered into a Master Service Agreement (the "MSA") with Tools for Humanity ("TFH") and the World Foundation ("WF"), and will support World ID adoption with the installation of Orbs across 3,000 locations nationwide in Japan. Tools for Humanity was co-founded by Sam Altman and Alex Blania and led the initial development of the World Project. The Orb is a device that allows an individual to verify that they are a unique human, and create a secure an
TOKYO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), announces that the cumulative number of Proof of Human authentications using the World ID authentication device ‘Orb' at stores centered on the relaxation salon "Re.Ra.Ku," operated by its subsidiary MEDIROM Wellness Co., surpassed 20,000 as of December 28, 2025. The Company participates in World (a Proof of Human authentication protocol), co-founded by Sam Altman and Alex Blania, and is advancing access to Proof of Human technology via the World Network. This milestone of surpassing 20,000 verifications represents a do
TOKYO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), a diversified healthcare company, collaborating with World Foundation and Tools for Humanity to deploy Proof of Human technologies such as World ID throughout Japan. The World project was co-created by Sam Altman and Alex Blania. In preparation for the full-scale rollout of the World project in Japan, MEDIROM has entered into a Master Service Agreement ("MSA") with Tools for Humanity ("TFH") and World Foundation ("WF"). Under the MSA, the MEDIROM Group will be responsible for the operation of "Proof of Human" verification
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company") is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. owned and operated ten cerebral infarction rehabilitation centers in Tokyo and other major cities across Japan. Cerebral infarction rehabilitation is a comprehensive program designed to
TOKYO, June 25, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company"), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), on June 18, 2024. Kouji Eguchi, Chief Executive Officer of the Company, stated, "I am very pleased to announce that during a period of significant investment and development in our healthcare technology systems and products in FY 2023 and FY 2022, as wel
NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its preliminary unaudited financial results for the fiscal year ended December 31, 2021, prepared in accordance with U.S. GAAP. Due to additional time required to complete its year-end reporting process, the Company determined that it was unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, within the prescribed time period without unreasonable effort and expense. The Company filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission o
NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan ("MEDIROM", the "Company"), today announced it will participate in a "NASDAQ JAPAN IR EVENT" to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience. PurposeIn December 2020, the Company became the first Japanese company in 21 years to list on Nasdaq. Today, the number of Japanese companies listed on Nasdaq has increased to eight. While more and mor
SC 13G - Medirom Healthcare Technologies Inc. (0001819704) (Subject)
SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)
SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)